查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
癌症切片检查市场:各产品，各切片检查类型 - 市场规模，占有率，展望，机会分析，2023年～2030年
市场调查报告书
商品编码
1330119

癌症切片检查市场:各产品，各切片检查类型 - 市场规模，占有率，展望，机会分析，2023年～2030年

Cancer Biopsy Market, By Product, Biopsy Type (((Tissue Biopsy (Needle Biopsy, Liquid Biopsy, and Others))), and By Application By Geography )- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

活检是一种医学测试，从体内采集组织或细胞样本并在实验室进行测试。另一方面，癌症活检涉及从受影响的患者身上取出组织或细胞，以发现癌症的存在、原因和程度。因此，随着全世界癌症负担的增加，癌症切片的使用也快速增加。

市场动态：

肿瘤疾病盛行率不断上升，老年人口不断增加，液体活检的出现和采用越来越多，公众对基因检测和遗传性肿瘤疾病的认识不断提高，活检技术不断改进。发展是预计促进肿瘤疾病成长的关键因素全球癌症切片市场。

本调查的主要特征

  • 本报告提供以2022年为基准年的预测期间（2023-2030 年）之全球癌症切片检查市场的市场规模和復合年增长率（CAGR %）相关的详区隔析。
  • 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球癌症切片检查市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球癌症切片检查市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球癌症切片检查市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

  • 调查目的
  • 前提条件
  • 简称

第2章 市场概况

  • 报告概要
    • 市场定义和范围
  • 摘要整理
  • Coherent Opportunity Map(COM)

第3章 市场动态，法规，趋势分析

  • 市场动态
    • 癌症病患的负担增加
    • 技术性及临床性课题
    • 液态生物检体引进的增加
  • 影响分析
  • 主要的焦点
  • 法规情势
  • 产品上市/核准
  • PEST分析
  • 波特分析
  • 合併·收购情势

第4章 癌症切片检查的全球市场-冠状病毒(COVID-19)流行的影响

  • COVID-19流行病学
  • 供给面和需求面的分析
  • 经济影响

第5章 癌症切片检查的全球市场:各产品，2023-2030年

  • 设备
  • 套件·消耗品
  • 服务

第6章 癌症切片检查的全球市场:各切片检查类型，2023-2030年

  • 组织切片检查
  • 针切片检查
  • 液态生物检体
  • 其他

第7章 癌症切片检查的全球市场:各用途，2023-2030年

  • 乳癌
  • 大肠癌症
  • 子宫颈癌症
  • 肺癌症
  • 前列腺癌症
  • 皮肤癌症
  • 血液癌症
  • 肾臟癌症
  • 肝臟癌症
  • 胰臟癌症
  • 卵巢癌症
  • 其他

第8章 癌症切片检查的全球市场:各地区，2023-2030年

  • 北美
  • 南美
  • 欧洲
  • 亚太地区
  • 中东

第9章 竞争情形

  • QIAGEN
  • Illumina, Inc.
  • Angle PLC
  • Myriad Genetics
  • COUNSYL, Inc.
  • Hologic, Inc.
  • Biocept, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Epigenomics AG
  • BD(Becton, Dickinson and Company)
  • Helio Health(Laboratory for Advanced Medicine)

第10章 章节

  • 调查手法
  • 关于出版社
简介目录
Product Code: CMI5930

A biopsy is a medical test to remove the piece of tissue or a sample of cells from the body so that it can be tested in a laboratory. While, in cancer biopsy, a tissue or cells of the affected patient is taken to discover the presence, cause, or extent of cancer. Thus, with the rising burden of cancer across the globe, the use of cancer biopsy or cancer biopsies also increasing with a rapid pace.

Market Dynamics:

Increasing prevalence of oncology disorders, growing geriatric population, advent of liquid biopsy or increasing adoption of liquid biopsies, increasing awareness among people about genetic testing and inherited oncology diseases, and ongoing developments in biopsy techniques are major factors expected to augment the growth of the global cancer biopsy market.

For instance, in May 2022, Delfi Diagnostics, a developer of a new class of high-performance and affordable liquid biopsy tests for early cancer detection, presented multiple applications for its next-generation liquid biopsy platform. Delfi presented a trial-in-progress update on DELFI-L101, a prospective, case-control study to train and test classifiers for lung cancer detection.

Key features of the study:

  • This report provides in-depth analysis of the global cancer biopsy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global cancer biopsy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include QIAGEN, Illumina, Inc., Angle PLC, Myriad Genetics, COUNSYL, Inc., Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, F. Hoffmann-La Roche Ltd., Epigenomics AG, BD (Becton, Dickinson and Company), and Helio Health (Laboratory for Advanced Medicine), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global cancer biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer biopsy market.

Detailed Segmentation:

  • Global Cancer Biopsy Market , By Product:
    • Instruments
    • Kits and Consumables
    • Services
  • Global Cancer Biopsy Market , By Biopsy Type:
    • Tissue Biopsy
      • Needle Biopsy
    • Fine Needle Aspiration (FNA)
    • Core Needle Biopsy (CNB)
    • Liquid Biopsy
    • Others
  • Global Cancer Biopsy Market, By Application:
    • Breast Cancer
    • Colorectal Cancer
    • Cervical Cancer
    • Lung Cancer
    • Prostate Cancer
    • Skin Cancer
    • Blood Cancer
    • Kidney Cancer
    • Liver Cancer
    • Pancreatic Cancer
    • Ovarian Cancer
    • Others
  • Global Cancer Biopsy Market , By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • QIAGEN
    • Illumina, Inc.
    • Angle PLC
    • Myriad Genetics
    • COUNSYL, Inc.
    • Hologic, Inc.
    • Biocept, Inc.
    • Thermo Fisher Scientific, Inc.
    • Danaher
    • F.Hoffmann-La Roche Ltd.
    • Epigenomics AG
    • BD (Becton, Dickinson and Company)
    • Helio Health (Laboratory for Advanced Medicine)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Biopsy Type
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising burden of oncology disorders
    • Technical and clinical challenges
    • Increasing adoption of liquid biopsies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Cancer Biopsy Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Cancer Biopsy Market, By Product, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Kits and Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Global Cancer Biopsy Market, By Biopsy Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Tissue Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Needle Biopsy
    • Fine Needle Aspiration (FNA)
    • Core Needle Biopsy (CNB)
  • Liquid Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

7. Global Cancer Biopsy Market, By Application, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Breast Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Colorectal Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Cervical Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Skin Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Blood Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Kidney Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Liver Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Pancreatic Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Ovarian Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

8. Global Cancer Biopsy Market, By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)

9. Competitive Landscape

  • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina, Inc.
  • Angle PLC
  • Myriad Genetics
  • COUNSYL, Inc.
  • Hologic, Inc.
  • Biocept, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Epigenomics AG
  • BD (Becton, Dickinson and Company)
  • Helio Health (Laboratory for Advanced Medicine)
  • Analyst Views

10. Section

  • Research Methodology
  • About us